Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Intranasal Oxytocin on Dysphagia Related to Oropharyngo-oesophageal Dysmotility in Children and Adolescents With Prader-Willi Syndrome: a Phase 2B Study

NCT05298085 is registered in ClinicalTrials.gov with University Hospital, Toulouse as lead sponsor.

NCT NCT05298085
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05298085 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Intranasal Oxytocin on Dysphagia Related to Oropharyngo-oesophageal Dysmotility in Children and Adolescents With Prader-Willi Syndrome: a Phase 2B Study
Lead sponsor
University Hospital, Toulouse
Phase
Phase 2/3
Overall status
Completed
Start date
April 5, 2022
Completion date
April 11, 2023
Enrollment
25 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

prader-willi syndrome